sardar-1920x750

Iran Center for Research and Training in Skin Diseases and Leprosy

The Center for Research and Training in Skin Diseases and Leprosy is a research institution affiliated to Tehran University of Medical Sciences. This center is active in research and training about skin diseases and leprosy.

History

The necessity of coordinating activities related to skin diseases and avoiding duplicated research projects in medical universities of the country persuaded the officials of Ministry of Health and Medical Education and Presidential Administration to establish a center for research on the skin diseases in 1992.

When it was established, the board of trustees for the Center for Research and Skin Diseases and Leprosy were: the president of that time (Ayatollah Hashemi Rafsanjani), the minister of Foreign Affairs (Dr. Ali Akbar Velayati), the minister of Health and Medical Education (Dr. Reza Malekzadeh), the head of Imam Khomeini Relief Foundation (Mr. Nayeri) and Dr. Yahya Dowlati.

Proposed by the board of trustees and approved by the minister of Health and Medical Education, Dr. Yahya Dowlati was appointed as the head of the Center for Research and Training in Skin Diseases and Leprosy.

The main responsibility of this Center is to create coordination among all research and training activities about skin diseases and leprosy.

In 1993, the Center for Research and Training in Skin Diseases and Leprosy separated from the Ministry of Health and Medical Education and joined Tehran University of Medical Sciences.

General Policies:

  • Performing research on epidemiology of common skin diseases with an emphasis on the lieshmaniasis and leprosy in Iran.
  • Performing research on immunopathogenesis of lieshmaniasis with an emphasis on finding surrogate markers for immunity against skin lieshmaniasis.
  • Performing research on production and evaluation of lieshmania vaccine, and standardizing and improving lieshmanization method in GMP and GLP laboratories as a way to evaluate lieshmania vaccine and a way to prevent lieshmaniasis disease.
  • performing research on effective medications for lieshmaniasis and optimizing treatment methods.
  • Training all skin assistants and medical students around the country in identifying new leprosy cases and full MDT coverage to eliminate leprosy based on the WHO plan.
  • Holding GCP training courses to standardize and internalize medical researches in the country with cooperation of WHO.
  • Establishing new methods for specialized treatment of skin cancer, including MOHS’ surgery and PDT.
  • Performing research on treatment of skin diseases by laser.

Clinical trial of new drugs for treating skin diseases based on GCP.